Catechol-O-methyl Transferase and Expression of Schizophrenia in 73 Adults with 22q11 Deletion Syndrome
- 11 January 2007
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 61 (10) , 1135-1140
- https://doi.org/10.1016/j.biopsych.2006.07.038
Abstract
No abstract availableKeywords
Funding Information
- Ontario Mental Health Foundation
- Medical Research Council Canada (MOP-38099)
- W. Garfield Weston Foundation
This publication has 36 references indexed in Scilit:
- Neurocognitive profile in 22q11 deletion syndrome and schizophreniaSchizophrenia Research, 2006
- Analysis of an association between the COMT polymorphism and clinical symptomatology in schizophreniaNeuroscience Letters, 2006
- A survey of the 22q11 microdeletion in a large cohort of schizophrenia patientsSchizophrenia Research, 2005
- Effects of a Functional COMT Polymorphism on Prefrontal Cognitive Function in Patients With 22q11.2 Deletion SyndromeAmerican Journal of Psychiatry, 2004
- Assessment of the frequency of the 22q11 deletion in Afrikaner schizophrenic patientsAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2004
- Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: SchizophreniaAmerican Journal of Human Genetics, 2003
- Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophreniaMolecular Psychiatry, 2002
- D1 receptors in prefrontal cells and circuitsBrain Research Reviews, 2000
- Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disordersPharmacogenetics, 1996
- Possible role for COMT in psychosis associated with velo-cardio-facial syndromeThe Lancet, 1992